Clinicalpathological analysis of risk factors for the development of hepatocellular carcinoma after surgery for esophageal varices due to underlying cirrhosis or pre-cirrhosis in the 397 patients

Hepatology Research

Volumn 25, Issue 1, 2003, Pages 62-70

  Sato, Yasunari ^a   Iwata, Toyohito ^a   Yoshimoto, Jiro ^a   Kojima, Kuniaki ^a   Futagawa, Shunji ^a   Matsumoto, Toshiharu ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0037240597     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00202-4     Document Type: Review

References (16)

1. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for historyogical assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-9.
2. The Ministry of Health and Welfare Commissioner's Secretariat Statistics and Information Department, Vital Statistics 1999, editor. Welfare Statistics Association, Tokyo, 1999 (in Japanese).
3. Report on the 14th Nationwide Follow-up Study of Primary Hepatocellular Carcinoma 1996-1997. Liver 2000;12:799-811 (in Japanese with English abstract).
4. Yoshida H, Shiina S, Shiratori Y, Omata M. For treatment of chronic hepatitis C taking hepatocellular carcinoma into account. Nihon Ijishinpo 1995;3706:23-7 (in Japanese).
5. Takase K, Nakano T, Tameda Y, Kosaka Y. Clinic and histologic features of chronic hepatitis virus C. Nihon Rinsho 1995;53 (extra issue):662-6 (in Japanese).
6. Ikeda K, Saito S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. Disease progression and hepatocellular carcinogenosis in patients with chronic vial hepatitis: prospective observation of 2215 patients. J Hepatol 1998;28:930-8.
7. Tanigawa H, Sada M. Follow-up and prognosis of chronic hepatitis. Jap J Int Med 1994;83:62-6 (in Japanese).
8. Uura M, Terasaki S, Urabe K, Matsushita E, Kaneko S, Kobayashi K. Change of prognosis of cirrhosis and hepatocellular carcinoma. Kan Tan Sui 1993;26:257-62 (in Japanese).
9. Ikeda K, Saito S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenosis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
10. Hagen TM, Hung S, Curnutte J, Fowler P, Martinez V, Wehr Cm, et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994;91:12808-12.
11. Yoshimoto J, Iwata T, Takamori S, Kojima K, Futagawa S. Usefulness of monoclonal antibody Ki-67 as aprognostic factor of hepatocellular carcinoma. Int Hepatol Commun 1997;6:09-218.
12. Iwata T, Yoshimoto J, Kojima K, Fukasawa M, Beppu T, Futagawa S. Studies on the risk factor for development of hepatocellular carcinoma after operation for portal hypertention-investigation by immuneohistochemical staining with MIB-1 antibody. J PHEV 1997;3:233-9 (in Japanese with English abstract).
13. Tarao K, Shimizu A, Ohkawa S, Tamagawa S, et al. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatictomized cirrhotic patient with hepatocellular carcinoma. Kan Tan Sui 1995;31:195-207.
14. Yamanouchi M, Toda G. To what extent do liver function tests show pathologic processes? Sogo Rinsho 1993;42:834-40 (in Japanese).
15. Harada H. Serum transaminases and their significance in impaired liver function. Jap J Gastroenterol 1958;55:591-604 (in Japanese).
16. Anderson FH, Zeng L, Rock NR, Eric M. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol Res 2001;18:63-71.